Fast Track Designation follows announcement in January 2024 that the U.S. Food and Drug Administration (FDA) granted a “Study May Proceed” letter for APRINOIA’s planned Phase 3 study of APN-1607 ...
LambdaTest's integration with PractiTest enhances testing capabilities, streamlining bug tracking and management for efficient software delivery.
San Francisco, May 21, 2024 (GLOBE NEWSWIRE) -- La...